ESMO Asia-Week 2021 - ESMO Asia Virtual Oncology Week 2021
Nov 17 - Nov 23, 2021 | SingaporeSingapore
LARVOL is not affiliated with ESMO Asia Virtual Oncology Week 2021 and all trademarks, logos, and brand names are property of their respective owners
Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID
Showing 2 abstracts linked to Trials
[VIRTUAL] ORIENT-31: Phase III study of sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated nonsquamous NSCLC who progressed after EGFR-TKI therapy
[VIRTUAL] Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial